Regulatory TEVAR clinical trials

被引：6
|
作者：
Garcia-Toca, Manuel [1 ]
Eskandari, Mark K. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Div Vasc Surg, Chicago, IL 60611 USA
来源：
JOURNAL OF VASCULAR SURGERY | 2010年 / 52卷
关键词：
THORACIC AORTIC-ANEURYSMS; ENDOVASCULAR TREATMENT; REPAIR; GRAFT;
D O I：
10.1016/j.jvs.2010.06.140
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：22S / 25S
页数：4
相关论文
共 50 条
  • [31] Regulatory approval of clinical trials: is it time to reinvent the wheel?
    Saleh, Mansoor
    Sharma, Karishma
    Shamshudin, Aisleen
    Obayo, Innocent
    Gondi, Stacey
    Karimi, Noureen
    BMJ GLOBAL HEALTH, 2024, 9 (01):
  • [32] Global Consultation on Regulatory Requirements for Xenotransplantation in Clinical Trials
    Cooper, David K. C.
    XENOTRANSPLANTATION, 2009, 16 (02) : 58 - 60
  • [33] Appropriate pharmacogenomic approaches in clinical trials for regulatory submission
    Uyama, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 46P - 46P
  • [34] Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges
    Mishra, Sangita
    Venkatesh, Mp
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [35] Digital Tools-Regulatory Considerations for Application in Clinical Trials
    Gelis, Lian
    Stoeckert, Isabelle
    Podhaisky, Hans-Peter
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (04) : 769 - 782
  • [36] Regulatory reform UK clinical trials process too complex
    Adriaanse, Chris
    CHEMISTRY & INDUSTRY, 2011, (02) : 7 - 7
  • [37] Clinical trials in "emerging markets": Regulatory considerations and other factors
    Singh, Romi
    Wang, Ouhong
    CONTEMPORARY CLINICAL TRIALS, 2013, 36 (02) : 711 - 718
  • [38] ASSESSING THE IMPLEMENTABILITY OF REGULATORY AGENCIES' GUIDANCE ON DIVERSITY IN CLINICAL TRIALS
    Metcalfe, R.
    Reshef, S.
    Park, J.
    VALUE IN HEALTH, 2024, 27 (06) : S209 - S209
  • [39] Subgroup analyses in randomized clinical trials: Statistical and regulatory issues
    Grouin, JM
    Coste, M
    Lewis, J
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2005, 15 (05) : 869 - 882
  • [40] Statistical challenges in a regulatory review of cardiovascular and CNS clinical trials
    Hung, H. M. James
    Wang, Sue-Jane
    Yang, Peiling
    Jin, Kun
    Lawrence, John
    Kordzakhia, George
    Massie, Tristan
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (01) : 37 - 43
12345